Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Notices 2681 

applicable Privacy Act Federal 

Acquisition Regulation (FAR) clauses in 

the solicitations and contracts. 

Physical Safeguards: Controls to 

secure the data and protect paper and 

electronic records, buildings, and 

related infrastructure against threats 

associated with their physical 

environment include the use of the HHS 

Employee ID or badge number and NIH 

key cards, security guards, cipher locks, 

biometrics, and closed-circuit TV. Paper 

records are secured in locked file 

cabinets, offices and facilities. 

Electronic media are kept on secure 

servers or computer systems. 

Technical Safeguards: Controls 

executed by the computer system are 

employed to minimize the possibility of 

unauthorized access, use, or 

dissemination of the data in the system. 

Examples include user identification, 

password protection, firewalls, virtual 

private network, encryption, intrusion 

detection system, common access cards, 

smart cards, biometrics and public key 

infrastructure. 

RECORD ACCESS PROCEDURES: 

This system of records is exempt from 

access under the Privacy Act to the 

extent that providing access to a subject 

individual would reveal the identity of 

a source who furnished information to 

the Federal Government under an 

express promise that the identity of the 

source would be held in confidence. 

However, DLR will consider all access 

requests addressed to the System 

Manager. To request access to a record 

about you, write to the System Manager 

at the address identified above, and 

reasonably specify the record contents 

sought. The request should include (a) 

your full name, (b) your address, (c) the 

approximate date(s) the information was 

collected, (d) the type(s) of information 

collected, and (e) the office(s) or 

official(s) responsible for the collection 

of information. You may also request an 

accounting of disclosures, if any, that 

have been made of any records 

maintained about you. 

You must verify your identity by 

providing either (a) a notarization of 

your signed request or (b) a written 

statement certifying under penalty of 

perjury that you are the individual who 

you claim to be, and that you 

understand that the knowing and willful 

request for a record pertaining to an 

individual under false pretenses is a 

criminal offense under the Privacy Act, 

subject to a fine of up to five thousand 

dollars. 

CONTESTING RECORD PROCEDURES: 

This system of records is exempt from 

the amendment provisions of the 

Privacy Act to the extent that 

responding to an amendment request 

would reveal the identity of a source 

who furnished information to the 

Federal Government under an express 

promise that the identity of the source 

would be held in confidence. However, 

DLR will consider all amendment 

requests addressed to the System 

Manager. To contest information in a 

record about you, write to the System 

Manager identified above, provide the 

same information required for an access 

request, and verify your identity in the 

manner required for an access request. 

Reasonably identify the record and 

specify the information contested, state 

the corrective action sought and the 

reason(s) for requesting the correction, 

and include any supporting 

documentation. The right to contest 

records is limited to information that is 

factually inaccurate, incomplete, 

irrelevant, or untimely (obsolete). 

NOTIFICATION PROCEDURES: 

This system of records is not exempt 

from the notification provisions of the 

Privacy Act. To request notification of 

whether this system of records contains 

a record about you, you must make a 

written request to System Manager 

identified above, provide the same 

information required for an access 

request, verify your identity in the 

manner required for an access request, 

and include the name and number of 

this system of records. 

EXEMPTIONS PROMULGATED FOR THE SYSTEM: 

The records in this system of records 

constitute investigatory material 

compiled solely for the purpose of 

determining suitability, eligibility, or 

qualifications for federal contracts 

pursuant to 5 U.S.C. 552a(k)(5). The 

system of records is exempt from the 

access, amendment, and accounting of 

disclosures requirements of the Privacy 

Act, at 5 U.S.C. 552a(c)(3) and (d)(1) 

through (4), to the extent that 

compliance with those requirements 

would reveal the identity of a source 

who furnished information to the 

Federal Government under an express 

promise that the identity of the source 

would be held in confidence. 

HISTORY: 

67 FR 6043 (Feb. 8, 2002), 83 FR 6591 

(Feb. 14, 2018). 

[FR Doc. 2020–28887 Filed 1–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurotoxicology 

and Alcohol Study Section. 

Date: February 11–12, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sepandarmaz Aschrafi, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040D, 

Bethesda, MD 20892, (301) 451–4251, 

Armaz.aschrafi@nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging Probes and 

Contrast Agents Study Section. 

Date: February 11–12, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Donald Scott Wright, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

8363, wrightds@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Human 

Studies of Diabetes and Obesity Study 

Section. 

Date: February 11–12, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Hui Chen, MD, Scientific 

Review Officer, Center for Scientific Review, 

2682 Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Notices 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6164, Bethesda, MD 20892, 301– 

435–1044, chenhui@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Psychosocial Risks and Disease 

Prevention. 

Date: February 11, 2021. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Weijia Ni, Ph.D., Chief/ 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3100, 

MSC 7808, Bethesda, MD 20892, 301–594– 

3292, niw@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Bioengineering, 

Technology and Surgical Sciences Study 

Section. 

Date: February 16–17, 2021. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Khalid Masood, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5120, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2392, masoodk@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; Vector 

Biology Study Section. 

Date: February 16–17, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liangbiao Zheng, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3214, 

MSC 7808, Bethesda, MD 20892, 301–402– 

5671, zhengli@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Tumor Progression and Metastasis Study 

Section. 

Date: February 16–17, 2021. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rolf Jakobi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6187, 

MSC 7806, Bethesda, MD 20892, 301–495– 

1718, jakobir@mail.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Biomarkers Study Section. 

Date: February 16–17, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–357– 

9318, ngkl@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Molecular and 

Integrative Signal Transduction Study 

Section. 

Date: February 16, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Charles Selden, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5187, 

MSC 7840, Bethesda, MD 20892, 301–451– 

3388, seldens@mail.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group; 

Hemostasis, Thrombosis, Blood Cells and 

Transfusion Study Section. 

Date: February 16–17, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9497, zouai@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Macromolecular Structure 

and Function A Study Section. 

Date: February 16–17, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David R. Jollie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

MSC 7806, Bethesda, MD 20892, (301) 408– 

9072, jollieda@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Addiction Risks and Mechanisms Study 

Section. 

Date: February 16–17, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kristen Prentice, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3112, 

MSC 7808, Bethesda, MD 20892, (301) 496– 

0726, prenticekj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 7, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00492 Filed 1–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Pathophysiology of Eye Disease—2 

Study Section. 

Date: February 11–12, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Julius Cinque, MSC, MS 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1252, cinquej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neuroimmunology and Brain Tumors. 

Date: February 11, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting).